Exelixis Inc. buy melinda
Start price
14.03.16
/
50%
€3.66
Target price
19.05.16
€5.41
Performance (%)
31.15%
End price
19.05.16
€4.80
Summary
This prediction ended on 19.05.16 with a price of €4.80. With a performance of 31.15% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Exelixis Inc. | 0.158% | 0.158% | 6.787% | 150.926% |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% | 64.548% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% | 110.363% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% | 55.210% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% | 70.174% |
Comments by melinda for this prediction
In the thread Exelixis Inc. diskutieren
métastase rénale
cancer